← Back to headlines

GLP-1 Agonists Transform Obesity Treatment Landscape
GLP-1 receptor agonists are revolutionizing obesity treatment by achieving significant and sustainable weight loss through their effects on the central nervous system, as discussed by Professor Stavroula Paschou.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
%2CxPosition%3D.5%2CyPosition%3D.5%3BResize%3D(1200%2C675)%26impolicy%3Dmedium&w=828&q=75&output=webp&default=1)


